|
not, however, consider the results of urine or other specimens that are not obtained or processed in
<br />accordance with DOT regulations.
<br />Results.'' The MRO will use staff under his direct supervision to handle administrative processes
<br />for negative test results including receiving the iresult from the laboratory, reviewing the paperwork for
<br />accuracy, and reporting of the result to the DER.
<br />The MRO staff may make the initial contact with employees having confirmed positive, adulterated,
<br />substituted, and invalid test results, for the purposes of setting up an interview for the MRO. The
<br />MRO will personally conduct the interview with the employee to determine whether there is a
<br />legitimate medical explanation for these results. This interview will be conducted, in most cases,
<br />before the Company is notified. If the result is confirmed positive by the laboratory, and a legitimate
<br />medical explanation is established, the MRO will report the result to the DER as negative. If not, the
<br />MRO will report the result to the DER as positive. If the confirmed result is adulterated or substituted,
<br />and a legitimate medical' explanatlon is established, the MRO will report the result to the DER as
<br />cancelled and notify ODAPC, in accordance with Part 40 procedures. If not, the MRO will report the
<br />result to the DER as a refusal to test. If the result is invalid, and an acceptable reason is established,
<br />the MRO will report the result to the DER as cancelled and the process will stop, unless a negative
<br />test result Is needed (e,g., pre -employment, return -to -duty and follow-up). If an acceptable reason Is
<br />not established, the MRO will report the result to the DER as cancelled and order an immediate
<br />recollection under direct observation.
<br />Reports.s' All drug test results will be reported to the Company 'DER in a confidential and timely
<br />manner. Before reporting any results, the MRO will have received a copy of the CCF showing where
<br />the employee has signed the form. The time period from collecting the specimen to re -porting the
<br />verified test result is generally shorter for negatives than for non -negatives. Non -negatives will not be
<br />reported to the DER until all Information required for the employee interview is received and approved
<br />by the MRO. The Company may use a. CITPA as Its intermediary in receiving drug test results. If so,
<br />those reports will be handled in accordance with Part 40 requirements. If the MRO does not use
<br />Copy 2 of the CCF for reporting results, the MRO will maintain a copy of the signed or stamped report
<br />in addition to the signed or stamped and dated Copy 2. If the MRO uses an electronic data file to
<br />report negatives, the MRO will maintain a retrievable copy of that report in a format suitable for
<br />inspection and auditing by a DOT representative.
<br />9. Split Specimen Testing
<br />Split Specimen. SB When the MRO has verified a result as positive, adulterated, or substituted, the
<br />MRO will notify the employee of their right to have the split specimen tested. The employee must
<br />notify the MRO within 72 hours of the result being verified in order to have this testing conducted. If
<br />the employee requests that the split specimen be tested within the 72-hour period, the MRO will
<br />ensure that the split specimen Is tested, Testing of the split specimen is only conducted at the request
<br />of the employee, and then only after using the MRO as the requesting agent for the employee.
<br />The Company is responsible for making sure that the MRO, first laboratory, and second laboratory
<br />perform the functions noted in Part 40 in a timely manner, once the employee has made a timely
<br />request for a test of the split specimen (e.g., by establishing appropriate accounts with laboratories
<br />for testing split specimens).
<br />The Company must not condition compliance with these requirements on the employee's direct
<br />payment to the MRO or laboratory or the employees agreement for reimbursement of the costs of
<br />testing. For example, if the Company's asks the employee to pay for some or all of the cost of testing
<br />the split specimen, and the employee is unwilling or unable to do so, the Company must ensure that
<br />the test takes place to a timely manner, which means that the Company will pay for the split testing.
<br />The Company may seek payment or reimbursement of all or part of the cost of the split specimen
<br />from the employee. Part 40 takes no position on who ultimately pays the cost of the test, so long as
<br />the Company ensures that the testing is conducted as required and the results released
<br />appropriately.
<br />Laboratory." The testing of the ,split specimen will be conducted at another HHS-certified
<br />laboratory, different from, the original laboratory. The Company will select the second laboratory. The
<br />split specimen will be tested for the same substance or condition that was found in the primary
<br />J. RANCK ELECTRIC, INC.
<br />PHMSA DRUG/ALCOHOL PLAN
<br />NATIONAL COMPL IANCE MANAGEMENT SERVICE, INC. (,NCMS) - 2M 25
<br />
|